Introduction
The Ugandan HIV-1 epidemic, with a prevalence of 7.3% [1] , is predominantly composed of subtype A, D and recombinant viruses [2, 3] . HIV-1 subtype affects the rate of disease progression [4] , yet it is not clear why. Subtype D is associated with faster progression to AIDS ( [5] , reviewed in [6, 7] ), more profound loss of CD4 þ T cells [5, 8] and decreased frequency of invariant natural killer T cells [9] , as compared with subtype A. Further studies of subtype D infection are warranted to understand subtypedependent differences in HIV-1 immunopathogenesis.
Natural killer (NK) cells are an integral part of the innate immune response to viruses [10] . HIV-1 infection, however, contributes to a range of changes in NK cell phenotype and function as early as primary infection [11] [12] [13] [14] [15] . In addition, HIV-1 can acquire escape mutations under NK cell immune pressure [16] , although certain killer immunoglobulin-like receptor (KIR) alleles, primarily expressed by NK cells, are associated with slower progression to AIDS [17] . Furthermore, the KIR repertoire of the NK cell compartment adapts and changes during the response to HIV-1 infection [18, 19] .
NK cells interact with dendritic cells and T cells to shape the immune response to infection. This cross-talk involves the activation of NK cells via interleukin (IL)-
12 and IL-18 to release type II interferon, which in turn matures dendritic cells to adequately prime T-cell responses [20, 21] . Disruption of the NK-dendritic cell communication may adversely impact immune control of HIV [22, 23] . Cytokine-activated NK cells can migrate to lymph nodes [24] , and directly activate T cells [25] . Cell-surface receptors such as NKG2A and CD57 can be used to describe CD56 dim NK cell differentiation [26] . In the present study, we investigated NK cell activation, differentiation and function in Ugandans with chronic untreated HIV-1 subtype D-infection.
Materials and methods
Study cohort and samples Study participants were randomly selected from a prospective community-based cohort to characterize HIV-1 infection in Rakai, Uganda, from 1998 until 2004 [5] prior to the availability of antiretroviral therapy in this setting. Cryopreserved peripheral blood mononuclear cells (PBMCs) from 42 treatment-naive individuals infected with HIV-1 subtype D and 28 communitymatched HIV-uninfected controls were selected for study (Table 1) . Walter Reed Army Institute of Research, Human Subjects Protection Branch (WRAIR#1428), as well as the Uganda National Council of Science and Technology (HS413) approved this study, and all participants provided written consent for participation and for use of stored samples. Plasma viral load was measured using Amplicor HIV-1 Monitor test version 1.5 (Roche Diagnostics, Indianapolis, Indiana, USA). HIV-1 subtypes were determined using the previously described multiregion hybridization assay (MHA acd, [27] ). The FACS MultiTEST IMK Kit (BD Biosciences, San Jose, California, USA) was used to enumerate lymphocyte subsets on a dual-laser FACSCalibur (BD Biosciences).
Flow cytometry
Whole blood collected in acid citrate dextrose anticoagulant was processed within 8 h and PBMC cryopreserved at -130 o C in liquid nitrogen, as previously described [28] . PBMCs were thawed and washed in RPMI medium containing 10% foetal bovine serum, 5% L-glutamine, 1% penicillin/streptomycin and 5% HEPES, and cell concentration and viability determined using Guava Viacount reagent and the Guava Personal Cell Analysis System (EMD Millipore, Billerica, Massachusetts, USA) [28] . Samples were stained in 96-well U-bottom plates at 4 o C for 30 min in the dark [12] . Aqua Live-Dead stain (Life Technologies Corporation, Carlsbad, California, USA) was used to discriminate viable cells. Commercially available mAbs included anti-CD3, anti-CD14 and anti-CD19 (all on APC-H7), anti-CD56 PE-Cy7, anti-Ki67 PE and anti-HLA-DR V450 (BD Biosciences). Additional mAbs included anti-NKG2A APC (Beckman Coulter, Inc., Brea, California, USA), anti-CD57 FITC (BioLegend, San Diego, California, USA) and anti-perforin PE (eBioscience, San Diego, California, USA). Ki67 and perforin were stained intracellularly after permeabilization using BD Perm/Wash (BD Biosciences). To assess NK cell function, thawed PBMCs were cultured overnight, in the presence of brefeldin A (BD Biosciences), with 10 ng/ml rIL-12 (R&D systems) as well as 10 ng/ml rIL-18 (MBL), or the MHCnull K562 cell line (at an E:Tof 5:1), or media alone [12] . Samples were fixed, washed, permeabilized and stained with anti-IFNg PE (BD Biosciences). All samples were acquired on an eight-colour BD FACSCanto II (BD Biosciences) and analysed using FlowJo version 9.5.3 (Tree Star, Ashland, Oregon, USA).
Statistical analysis
Graph Pad Prism version 6.0a for Mac OSX was used for statistical analysis (GraphPad Software, La Jolla, California, USA). Differences between groups were analysed using the Mann -Whitney test and associations were determined using Spearman's rank correlation. P values less than 0.05 were considered statistically significant. 
Results

Impaired
CD19
À and CD56 þ gating (Fig. 1a) . After stimulation with IL-12 and IL-18, CD56 dim NK cells in HIV-infected individuals produced less IFNg than those from uninfected controls (P ¼ 0.026, Fig. 1b) . The overall trend towards lower absolute counts of CD56 dim NK cells (P ¼ 0.07, data not shown) in HIV infection enhanced this pattern in absolute count terms with diminished counts of IFNgþ CD56 dim NK cells in infected individuals (P < 0.001, Fig. 1c ). In contrast, IFNg production in CD56 dim NK cells in HIV-infected individuals was unimpaired after K562 stimulation (P ¼ 0.5, Fig. 1d ), although the overall trend towards lower absolute counts of CD56 dim NK cells led to a lower representation of cells responding to K562 measured as an absolute count (P ¼ 0.036, Fig. 1e ). Expression of Ki67 and the cytolytic protein perforin were similar regardless of infection status (data not shown). Fig. 1f ) and as an absolute count of this subset of CD56 dim NK cells (P < 0.001, Fig. 1g ). The proportions of cells defined by other combinations of these markers (NKG2A
CD57
þ cells was not directly related to an increase in one of the other subsets (data not shown). Furthermore, the NKG2A þ
þ CD56 dim NK cell subset was more activated, as determined by HLA-DR expression, in a subset of 18 of the individuals when compared with 19 controls (P ¼ 0.011; Fig. 1h ).
NKG2A
R CD57 R CD56 dim natural killer cell frequency correlates with CD56 dim interferongamma production We next investigated whether the decline in NKG2A 
CD57
þ CD56 dim NK cells correlated directly with CD56 dim IFNg production in response to IL-12 as well as IL-18 stimulation (rho ¼ 0.568, P < 0.001; Fig. 1i ), but not K562 stimulation (rho ¼ 0.030, P ¼ 0.85; Fig. 1j ). This association was not observed in controls (rho ¼ -0.080, P ¼ 0.68; data not shown). Surprisingly, cytokine-induced IFNg production in NKG2A þ
þ CD56 dim NK cells did not differ between cases and controls (Fig. 1k) . This suggests that the functional capacity of NKG2A
dim NK cells may not be directly affected on a percell basis, and that their decline may be associated with the functional capacity of the global CD56 dim NK cell compartment. Of note, these phenotypic and functional parameters did not correlate with CD4 þ cell count or viral load (data not shown).
Discussion
To better understand the innate immunology of HIV-1 subtype D infection in Rakai, Uganda, we studied NK cell responses to IL-12 as well as IL-18 stimulation.
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CD56
dim NK cells from HIV-positive individuals produced less IFNg in response to cytokine stimulation, as compared with uninfected controls. This is in line with previous findings from a US cohort, despite the geographic, host and viral disparity between these populations [29] . Expression of the inhibitory receptor NKG2A and the terminal differentiation marker CD57 together identified a subset of CD56 dim NK cells that was reduced in HIV-1 subtype D infection. These NKG2A [26] . Previous studies have indicated that NKG2A expression correlates with the IFNg response to IL-12 as well as IL-18 cytokine stimulation [30] , and that CD57 expression reflects the cytolytic potential of NK cells in the form of perforin and granzyme expression [31] . NKG2A
cells may be in an intermediate differentiation phase, retaining responses to cytokine stimulation and in transition to a more differentiated phenotype [24] . Our finding that the decline of the NKG2A
dim NK cell subset is associated with impaired NK cell responses to cytokine stimulation suggests a possible important role for this subset in NK cell homeostasis and function.
Pathogen-associated maturational skewing of NK cells has been observed previously. NK cells reconstituting in patients after umbilical cord blood transplantation mature more rapidly in patients infected with cytomegalovirus [32] , a pattern also seen in primary HIV infection [33] . Hong et al. [34] observed a decline of less differentiated NK cells in chronic untreated HIV-1 infection. In addition, Marras et al. [35] recently showed that activation, as measured by HLA-DR, of CD56 dim NK cells in HIV-1 viremic controllers is associated with differentiation to an NKG2A À
CD57
þ effector phenotype. Chronic viral infection has also been associated with a defect in miR-155, which is important for IFNg production [36] , maturation and expansion of IL-12 and IL-18 activated NK cells [37] . In this context, the decline in the activated NKG2A
dim subset could be a consequence of HIV-driven rapid maturation [34] that is not accompanied by expansion of the effector NK cell subset [32, 37] . This may reduce the number of NK cells available to produce IFNg.
Wright et al. [38] found lower plasma IFNg concentration in 'late stage' subtype D-infected patients than in subtype A-infected Ugandans at a similar disease stage. Others have also observed that IFNg secretion by NK cells declines during HIV-1 infection [39] and is not restored by antiretroviral therapy, despite recovery of phenotypically mature NK cells [29] . These observations, together with the lack of association of the IFNg 'defect' with CD4 þ cell count in the present study, may suggest that even relatively healthy HIV-infected individuals have damaged NK cell compartments. In summary, our findings support the notion that HIV-1 infection drives changes in NK cell maturation, with an altered distribution of maturational subsets, elevated expression of activation markers and lower responsiveness to cytokine stimulus.
